Clopidogrel and PPI Interaction: Clinically Relevant or Not? Robert W. HarrisonKenneth W. Mahaffey New Therapies for Cardiovascular Disease (KW Mahaffey, Section Editor) 17 November 2011 Pages: 49 - 58
Cardiac PET, CT, and MR: What Are the Advantages of Hybrid Imaging? Antti SarasteJuhani Knuuti Cardiac PET, CT, and MRI (S Achenbach, Section Editor) 17 November 2011 Pages: 24 - 31
Promise of Factor Xa Inhibition in Acute Coronary Syndromes Leong LeeDerek Chew New Therapies for Cardiovascular Disease (KW Mahaffey, Section Editor) 12 November 2011 Pages: 40 - 48
Projected and Observed Diabetes Epidemics in China and Beyond Dong ZhaoFan ZhaoZheng Zheng Diabetes and Cardiovascular Disease (ND Wong, Section Editor) 06 November 2011 Pages: 106 - 111
Low-Dose Cardiovascular Computed Tomography: Where are the Limits? Paul SchoenhagenCarla M. ThompsonSandra S. Halliburton Cardiac PET, CT, and MRI (S Achenbach, Section Editor) 05 November 2011 Pages: 17 - 23
The Prognostic Significance of Coronary CT Angiography Kevin M. WoodsCollin FischerTodd C. Villines Cardiac PET, CT, and MRI (S Achenbach, Section Editor) 04 November 2011 Pages: 7 - 16
What is the Role of Aldosterone Excess in Resistant Hypertension and How Should It Be Investigated and Treated? Domenic A. Sica Hypertension (Matthew Sorrentino, Section Editor) 13 October 2011 Pages: 520 - 526
What Is the Blood Pressure Goal for the Elder Patient 75 Years of Age or Older? Gary E. SanderThomas D. Giles Hypertension (Matthew Sorrentino, Section Editor) 05 October 2011 Pages: 485 - 491
The Role of Triglycerides in Atherosclerosis Beatriz G. TalayeroFrank M. Sacks Lipid Abnormalities and Cardiovascular Prevention (Michael H. Davidson, Section Editor) 04 October 2011 Pages: 544 - 552
Predictors of Statin Adherence Alexander MauskopWilliam B. Borden Lipid Abnormalities and Cardiovascular Prevention (Michael H. Davidson, Section Editor) 27 September 2011 Pages: 553 - 558
Apo A-I Modulating Therapies Stephen J. Nicholls Lipid Abnormalities and Cardiovascular Prevention (Michael H. Davidson, Section Editor) 24 September 2011 Pages: 537 - 543
Familial Hypercholesterolemia: Present and Future Management B. SjoukeD. M. KustersG. K. Hovingh Lipid Abnormalities and Cardiovascular Prevention (Michael H. Davidson, Section Editor) Open access 21 September 2011 Pages: 527 - 536
CETP Inhibition: Does the Future Look Promising? Peter P. Toth Lipid Abnormalities and Cardiovascular Prevention (Michael H. Davidson, Section Editor) 10 September 2011 Pages: 559 - 565
Should β Blockers No Longer Be Considered First-line Therapy for the Treatment of Essential Hypertension Without Comorbidities? William J. ElliottW. Kurtis Childers Hypertension (Matthew Sorrentino, Section Editor) 07 September 2011 Pages: 507 - 516
Coronary Artery Calcium: Utilization for Primary Prevention of CHD Harvey S. Hecht Editorial 03 September 2011 Pages: 465 - 474
What is the Ideal Blood Pressure Goal for Patients with Stage III or Higher Chronic Kidney Disease? Yazan KhouriSusan P. SteigerwaltPeter A. McCullough Hypertension (Matthew Sorrentino, Section Editor) 02 September 2011 Pages: 492 - 501
Stuck between Goal Achievement and Evidence-based Medicine Michael H. Davidson Clinical Trial Report 26 August 2011 Pages: 481 - 484
Is There a Role for Measuring Central Aortic Pressure? Yonghong HuanRaymond Townsend Hypertension (Matthew Sorrentino, Section Editor) 25 August 2011 Pages: 502 - 506
Can Treating the Diastolic Blood Pressure Below a Certain Value Increase Cardiovascular Risk? Norman M. Kaplan Hypertension (Matthew Sorrentino, Section Editor) 16 August 2011 Pages: 517 - 519
Can Catheter-Based Renal Denervation Be Used Safely and Effectively to Substantially Reduce Blood Pressure in Treatment-Resistant Hypertensive Patients? Suzanne Oparil Clinical Trial Report 16 August 2011 Pages: 478 - 480
Thienopyridine-Associated Drug-Drug Interactions: Pharmacologic Mechanisms and Clinical Relevance Jean-Sébastien HulotJean-Philippe ColletGilles Montalescot ReviewPaper 09 August 2011 Pages: 451 - 458
Utilizing Risk Scores in Determining the Optimal Revascularization Strategy for Complex Coronary Artery Disease Vasim FarooqSalvatore BrugalettaPatrick W. Serruys ReviewPaper Open access 06 August 2011 Pages: 415 - 423
The ACCOMPLISH Trial: Will First-Line Hypertension Therapy Change? Matthew J. Sorrentino Clinical Trial Report 06 August 2011 Pages: 475 - 477
Review of the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial: Warfarin Versus Dabigatran Christopher IngelmoOussama Wazni Clinical Trial Report 03 August 2011 Pages: 357 - 360
Atrial Fibrillation: Update on Ablation Strategies and Technology Prasanna K. ChallaMoussa Mansour ReviewPaper 02 August 2011 Pages: 394 - 398
Genotypic and Phenotypic Assessment of Platelet Function and Response to P2Y12 Antagonists Axel de LabriolleJean Philippe DoazanLaurent Bonello ReviewPaper 29 July 2011 Pages: 439 - 450
Bare-Metal Stents Versus Drug-Eluting Stents for Primary Angioplasty: Long-Term Outcome Emilio Di LorenzoGiannignazio CarboneRosario Sauro ReviewPaper 27 July 2011 Pages: 459 - 464
New Paradigms in the Prevention of Sudden Cardiac Arrest and Heart Failure Treatment Mustafa DohadwalaN. A. Mark Estes IIIMark S. Link ReviewPaper 26 July 2011 Pages: 377 - 386
Genetics of Sudden Cardiac Death Alon BarsheshetAndrew BrenyoIlan Goldenberg ReviewPaper 26 July 2011 Pages: 364 - 376
Percutaneous Coronary Interventions in Facilities Without Cardiac Surgery on Site Yuri B. PrideC. Michael Gibson ReviewPaper 13 July 2011 Pages: 432 - 438
Extraction of Implantable Cardiac Electronic Devices John RickardBruce L. Wilkoff ReviewPaper 12 July 2011 Pages: 407 - 414
Catheter-based Ablation for Ventricular Arrhythmias Roy M. JohnWilliam G. Stevenson ReviewPaper 09 July 2011 Pages: 399 - 406
Update on the Management of Atrial Fibrillation: Anticoagulation and Medical Therapy Shueh Hao LimHugh CalkinsSunil K. Sinha ReviewPaper 09 July 2011 Pages: 387 - 393
The Use of Drug-Eluting Stents Versus Bypass Surgery for Left Main Coronary Artery Disease Eric L. WallaceDavid J. Moliterno Clinical Trial Report 07 July 2011 Pages: 361 - 363
Revascularization for Unprotected Left Main Coronary Artery Disease: An Evolution in Clinical Decision Making David E. KandzariJohn A. Ormiston ReviewPaper Open access 05 July 2011 Pages: 424 - 431
How Serious a Problem is Bleeding in Patients with Acute Coronary Syndromes? Usman BaberJason KovacicRoxana Mehran ReviewPaper 11 June 2011 Pages: 312 - 319
Importance of Residual Myocardial Ischemia After Intervention in the Genesis of Cardiovascular Events Among Patients with Chronic Coronary Artery Disease Leslee J. ShawRory HachamovitchDaniel S. Berman ReviewPaper 09 June 2011 Pages: 280 - 286
Role of Coronary Artery Calcium Score and Coronary CT Angiography in the Diagnosis and Risk Stratification of Individuals with Suspected Coronary Artery Disease Sean R. WilsonFay Y. LinJames K. Min ReviewPaper 07 June 2011 Pages: 271 - 279
Beyond Aspirin and Clopidogrel: Is There a Need for Additional Antiplatelet Therapy in ACS? Lawrence RajanDavid J. Moliterno ReviewPaper 24 May 2011 Pages: 303 - 311
Personalized Antiplatelet Therapy: Review of the Latest Clinical Evidence Elise CamilleriLaurent JacquinLaurent Bonello ReviewPaper 19 May 2011 Pages: 296 - 302
Preventing Sudden Death in the Adult with Congenital Heart Disease Ronn E. Tanel ReviewPaper 11 May 2011 Pages: 327 - 335
Optimal Medical Therapy, Lifestyle Intervention, and Secondary Prevention Strategies for Cardiovascular Event Reduction in Ischemic Heart Disease Philip JosephKoon Teo ReviewPaper 10 May 2011 Pages: 287 - 295
Genetic Counseling in the Adult with Congenital Heart Disease: What is the Role? Luke BurchillSteven GreenwaySeema Mital ReviewPaper 03 May 2011 Pages: 347 - 355
Letter to the Editor: Asymptomatic Carotid Stenosis—More Misunderstandings in the Expectation of a Surgical Benefit Anne Abbott Letter to the Editor 27 April 2011 Pages: 265 - 267
Reply to the Letter by A. Abbott Regarding “Asymptomatic Carotid Stenosis—More Misunderstandings in the Expectation of a Surgical Benefit” Margaret H. WalkupPeter L. Faries Letter to the Editor 20 April 2011 Pages: 268 - 268
P2Y12 Antagonists in Acute Coronary Syndrome: In Whom Should They Be Started, and When? Christopher W. GoodPeter B. Berger ReviewPaper 13 April 2011 Pages: 320 - 326
Monitoring the Patient with Transposition of the Great Arteries: Arterial Switch Versus Atrial Switch Susan Lucy RocheCandice Kristine SilversidesErwin Notker Oechslin ReviewPaper 12 April 2011 Pages: 336 - 346
The Role of Exercise Testing for Predicting Pregnancy Outcomes in Women with Congenital Heart Disease Elyse Foster Clinical Trial Report 12 April 2011 Pages: 269 - 270
Treatment of Ventricular Tachycardia in Patients with Heart Failure Michael W. FongLuanda GrazetteLeslie Saxon ReviewPaper 29 March 2011 Pages: 203 - 209
Heart Failure Pharmacogenetics: Past, Present, and Future Heather M. DavisJulie A. Johnson ReviewPaper 18 March 2011 Pages: 175 - 184
